China News

103 readers

1 users here now

A community for china news

founded 5 months ago

MODERATORS

rss@news.abolish.capital

Salamence@lemmy.zip

RedWizard@news.abolish.capital

Salamence@mander.xyz

China’s weight-loss drug makers take on global giants as Novo Nordisk patent expires (www.scmp.com)

submitted 1 week ago by rss@news.abolish.capital to c/china@news.abolish.capital

0 comments fedilink hide all child comments

At least 10 weight-loss injections and oral pills are lining up for regulatory approval in China, in a market projected to reach about US$14 billion by 2030. Novo Nordisk’s blockbuster semaglutide, which generated about US$35 billion in global revenue last year, lost patent protection in China on March 20, clearing the way for rivals. The rush comes as China’s drug regulator accelerates approvals of innovative therapies, helped by a surge in out-licensing deals with global pharmaceutical...

From China - South China Morning Post via This RSS Feed.

no comments (yet)

sorted by: hot top controversial new old

there doesn't seem to be anything here